首页> 外文期刊>World Journal of Gastroenterology >Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis.
【24h】

Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis.

机译:通过抗氧化和抑制粘附分子合成改善黄芪对实验性结肠炎的改善作用。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To investigate the protective effects of Astragalus membranaceus (Am) against hapten-induced colitis in male Sprague-Dawley rats as well as its underlying mechanism. METHODS: Experimental colitis was induced in rats by enema administration of 2,4-dinitrobenzene sulfonic acid (DNBS). Rats were either pretreated with Am extract (2 or 4 g/kg, p.o. once daily) starting from 10 d before DNBS enema, or received Am post-treatment (2 or 4 g/kg, p.o. twice daily) on the three consecutive days following DNBS administration. Colonic lesion area and histological damage were determined, while the activities of myeloperoxidase (MPO) and xanthine oxidase, as well as reduced glutathione (GSH) content were measured in the excised colonic tissues. Besides, protein expression of inducible nitrite oxide synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1) and P-selectin was also detected by Western blot analysis. RESULTS: Our findings had shown that both macroscopic lesion area and histological colonic damage induced by DNBS were significantly reduced by both Am pre- and post-treatments. These were accompanied by attenuation of the elevated colonic MPO activity and downregulation of the iNOS, P-selectin, and ICAM-1 protein expression. Besides, deprivation of colonic GSH level under colitis condition was also preserved. CONCLUSION: These results demonstrate that Am possesses both preventive and therapeutic potential in experimental colitis. The anti-inflammatory actions involve anti-oxidation along with inhibition of adhesion molecule synthesis in the colonic tissues.
机译:目的:探讨黄芪对雄性Sprague-Dawley大鼠半抗原诱发的结肠炎的保护作用及其潜在机制。方法:灌肠给予2,4-二硝基苯磺酸(DNBS)可诱发大鼠实验性结肠炎。从DNBS灌肠前10天开始,用Am提取物(2或4 g / kg,每天一次,口服)对大鼠进行预处理,或连续三天接受Am后处理(2或4 g / kg,每天两次,口服)。 DNBS管理之后。确定结肠病变面积和组织学损伤,同时在切除的结肠组织中测量髓过氧化物酶(MPO)和黄嘌呤氧化酶的活性,以及​​减少的谷胱甘肽(GSH)含量。此外,还通过蛋白质印迹分析检测了诱导型亚硝酸盐合酶(iNOS),细胞间粘附分子-1(ICAM-1)和P-选择素的蛋白表达。结果:我们的研究结果表明,Am治疗前后,DNBS引起的宏观病变面积和组织学结肠损伤均明显减少。这些伴随着结肠MPO活性升高的减弱和iNOS,P-选择素和ICAM-1蛋白表达的下调。此外,结肠炎条件下结肠GSH水平的丧失也得以保留。结论:这些结果表明Am在实验性结肠炎中具有预防和治疗潜力。抗炎作用包括抗氧化以及结肠组织中粘附分子合成的抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号